Cargando…

Core decompression with β-tri-calcium phosphate grafts in combination with platelet-rich plasma for the treatment of avascular necrosis of femoral head

BACKGROUND: This study was aimed to investigate whether the application of platelet-rich plasma (PRP) combined with β-tri-calcium phosphate (β-TCP) grafts after core decompression (CD) could improve the clinical outcomes of early stage of avascular necrosis of femoral head. METHODS: Forty-five (54 h...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyu, Jinyang, Ma, Tiancong, Huang, Xin, Shi, Jingsheng, Huang, Gangyong, Chen, Feiyan, Wei, Yibing, Wang, Siqun, Xia, Jun, Zhao, Guanglei, Chen, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847169/
https://www.ncbi.nlm.nih.gov/pubmed/36650473
http://dx.doi.org/10.1186/s12891-022-06120-z
_version_ 1784871394850373632
author Lyu, Jinyang
Ma, Tiancong
Huang, Xin
Shi, Jingsheng
Huang, Gangyong
Chen, Feiyan
Wei, Yibing
Wang, Siqun
Xia, Jun
Zhao, Guanglei
Chen, Jie
author_facet Lyu, Jinyang
Ma, Tiancong
Huang, Xin
Shi, Jingsheng
Huang, Gangyong
Chen, Feiyan
Wei, Yibing
Wang, Siqun
Xia, Jun
Zhao, Guanglei
Chen, Jie
author_sort Lyu, Jinyang
collection PubMed
description BACKGROUND: This study was aimed to investigate whether the application of platelet-rich plasma (PRP) combined with β-tri-calcium phosphate (β-TCP) grafts after core decompression (CD) could improve the clinical outcomes of early stage of avascular necrosis of femoral head. METHODS: Forty-five (54 hips) patients with Ficat-Arlet classification stage I-II treated by CD with β-TCP grafts with or without the application of PRP from July 2015 to October 2020 were reviewed. Group A (CD + β-TCP grafts) included 24 patients (29 hips), while group B (CD + β-TCP grafts + PRP) included 21 patients (25 hips). Visual analogue scale (VAS) score, Harris hip score (HHS), change in modified Kerboul angle and the hip joint survival were evaluated and compared between the groups. Patients had a mean follow-up period of 62.1 ± 17.2 months and 59.3 ± 14.8 months in group A and group B, respectively. RESULTS: The mean VAS scores in group A was significantly higher than group B at the 6 months (2.9 ± 0.7 vs 1.9 ± 0.6, p < 0.01) and final follow up postoperative (2.8 ± 1.2 vs 2.2 ± 0.7, p = 0.04). The mean HHS in group A was significantly lower than group B at the 6 months (80.5 ± 13.8 vs 89.8 ± 12.8, p = 0.02). However, at the final follow up, there is no significant difference between the groups (77.0 ± 12.4 vs 83.1 ± 9.3, p = 0.07). The mean change in modified Kerboul angle was -7.4 ± 10.6 in group A and -19.9 ± 13.9 in group B which is statistically significant (p < 0.01). Survivorship from total hip arthroplasty were 86.2%/84% (p = 0.86) at the final follow up, which was not statistically significant. No serious complications were found in both groups. CONCLUSIONS: A single dose of PRP combined with CD and β-TCP grafts provided significant pain relief, better functional outcomes, and delayed progression in the short term compared to CD combined with β-TCP grafts. However, the prognosis of the femoral head did not improve significantly in the long term. In the future, designing new implants to achieve multiple PRP injections may improve the hip preservation rate.
format Online
Article
Text
id pubmed-9847169
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-98471692023-01-19 Core decompression with β-tri-calcium phosphate grafts in combination with platelet-rich plasma for the treatment of avascular necrosis of femoral head Lyu, Jinyang Ma, Tiancong Huang, Xin Shi, Jingsheng Huang, Gangyong Chen, Feiyan Wei, Yibing Wang, Siqun Xia, Jun Zhao, Guanglei Chen, Jie BMC Musculoskelet Disord Research BACKGROUND: This study was aimed to investigate whether the application of platelet-rich plasma (PRP) combined with β-tri-calcium phosphate (β-TCP) grafts after core decompression (CD) could improve the clinical outcomes of early stage of avascular necrosis of femoral head. METHODS: Forty-five (54 hips) patients with Ficat-Arlet classification stage I-II treated by CD with β-TCP grafts with or without the application of PRP from July 2015 to October 2020 were reviewed. Group A (CD + β-TCP grafts) included 24 patients (29 hips), while group B (CD + β-TCP grafts + PRP) included 21 patients (25 hips). Visual analogue scale (VAS) score, Harris hip score (HHS), change in modified Kerboul angle and the hip joint survival were evaluated and compared between the groups. Patients had a mean follow-up period of 62.1 ± 17.2 months and 59.3 ± 14.8 months in group A and group B, respectively. RESULTS: The mean VAS scores in group A was significantly higher than group B at the 6 months (2.9 ± 0.7 vs 1.9 ± 0.6, p < 0.01) and final follow up postoperative (2.8 ± 1.2 vs 2.2 ± 0.7, p = 0.04). The mean HHS in group A was significantly lower than group B at the 6 months (80.5 ± 13.8 vs 89.8 ± 12.8, p = 0.02). However, at the final follow up, there is no significant difference between the groups (77.0 ± 12.4 vs 83.1 ± 9.3, p = 0.07). The mean change in modified Kerboul angle was -7.4 ± 10.6 in group A and -19.9 ± 13.9 in group B which is statistically significant (p < 0.01). Survivorship from total hip arthroplasty were 86.2%/84% (p = 0.86) at the final follow up, which was not statistically significant. No serious complications were found in both groups. CONCLUSIONS: A single dose of PRP combined with CD and β-TCP grafts provided significant pain relief, better functional outcomes, and delayed progression in the short term compared to CD combined with β-TCP grafts. However, the prognosis of the femoral head did not improve significantly in the long term. In the future, designing new implants to achieve multiple PRP injections may improve the hip preservation rate. BioMed Central 2023-01-18 /pmc/articles/PMC9847169/ /pubmed/36650473 http://dx.doi.org/10.1186/s12891-022-06120-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Lyu, Jinyang
Ma, Tiancong
Huang, Xin
Shi, Jingsheng
Huang, Gangyong
Chen, Feiyan
Wei, Yibing
Wang, Siqun
Xia, Jun
Zhao, Guanglei
Chen, Jie
Core decompression with β-tri-calcium phosphate grafts in combination with platelet-rich plasma for the treatment of avascular necrosis of femoral head
title Core decompression with β-tri-calcium phosphate grafts in combination with platelet-rich plasma for the treatment of avascular necrosis of femoral head
title_full Core decompression with β-tri-calcium phosphate grafts in combination with platelet-rich plasma for the treatment of avascular necrosis of femoral head
title_fullStr Core decompression with β-tri-calcium phosphate grafts in combination with platelet-rich plasma for the treatment of avascular necrosis of femoral head
title_full_unstemmed Core decompression with β-tri-calcium phosphate grafts in combination with platelet-rich plasma for the treatment of avascular necrosis of femoral head
title_short Core decompression with β-tri-calcium phosphate grafts in combination with platelet-rich plasma for the treatment of avascular necrosis of femoral head
title_sort core decompression with β-tri-calcium phosphate grafts in combination with platelet-rich plasma for the treatment of avascular necrosis of femoral head
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847169/
https://www.ncbi.nlm.nih.gov/pubmed/36650473
http://dx.doi.org/10.1186/s12891-022-06120-z
work_keys_str_mv AT lyujinyang coredecompressionwithbtricalciumphosphategraftsincombinationwithplateletrichplasmaforthetreatmentofavascularnecrosisoffemoralhead
AT matiancong coredecompressionwithbtricalciumphosphategraftsincombinationwithplateletrichplasmaforthetreatmentofavascularnecrosisoffemoralhead
AT huangxin coredecompressionwithbtricalciumphosphategraftsincombinationwithplateletrichplasmaforthetreatmentofavascularnecrosisoffemoralhead
AT shijingsheng coredecompressionwithbtricalciumphosphategraftsincombinationwithplateletrichplasmaforthetreatmentofavascularnecrosisoffemoralhead
AT huanggangyong coredecompressionwithbtricalciumphosphategraftsincombinationwithplateletrichplasmaforthetreatmentofavascularnecrosisoffemoralhead
AT chenfeiyan coredecompressionwithbtricalciumphosphategraftsincombinationwithplateletrichplasmaforthetreatmentofavascularnecrosisoffemoralhead
AT weiyibing coredecompressionwithbtricalciumphosphategraftsincombinationwithplateletrichplasmaforthetreatmentofavascularnecrosisoffemoralhead
AT wangsiqun coredecompressionwithbtricalciumphosphategraftsincombinationwithplateletrichplasmaforthetreatmentofavascularnecrosisoffemoralhead
AT xiajun coredecompressionwithbtricalciumphosphategraftsincombinationwithplateletrichplasmaforthetreatmentofavascularnecrosisoffemoralhead
AT zhaoguanglei coredecompressionwithbtricalciumphosphategraftsincombinationwithplateletrichplasmaforthetreatmentofavascularnecrosisoffemoralhead
AT chenjie coredecompressionwithbtricalciumphosphategraftsincombinationwithplateletrichplasmaforthetreatmentofavascularnecrosisoffemoralhead